STAT
FEBRUARY 27, 2024
When my wife, Laurie, completed her ninth in vitro fertilization cycle in the spring of 2000, we had more than 150 fertilized embryos in frozen storage at the Center for Reproductive Medicine and Infertility at the NewYork Presbyterian Hospital-Weill Medical College of Cornell University. We were not stockpiling them for later use. At the time, our son Henry was 5.
PharmaVoice
FEBRUARY 27, 2024
The personal impact of rare disease has shaped Gianluca Pirozzi, a senior vice president at AstraZeneca’s Alexion, as a parent and drug developer.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
FEBRUARY 27, 2024
A much-anticipated inquiry by U.S. antitrust regulators into pharmaceutical industry middlemen has been stymied because the companies have failed to provide many of the documents that, in some cases, were requested as far back as June 2022. The inquiry was begun by the Federal Trade Commission in response to the role that pharmacy benefit managers play in the cost of prescription medicines.
BioPharma Dive
FEBRUARY 27, 2024
The biotech’s drug led to significant weight loss in a Phase 2 trial, causing shares to double as analysts compared results to the marks set by drugs from Eli Lilly and Novo Nordisk.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
FEBRUARY 27, 2024
An unprecedented shortage of cholera vaccine has public health experts fearing that a recent surge of outbreaks across developing countries will only worsen, a situation they argue is as regrettable as it was avoidable. At least 16 countries in Asia, Africa, and the Caribbean are dealing with cholera outbreaks. According to the latest report from the European Centre for Disease Prevention and Control , between Dec. 23 and Jan. 23, nearly 50,500 people contracted cholera and nearly 500 died.
pharmaphorum
FEBRUARY 27, 2024
Pharmaceutical companies are increasingly focusing on radiopharmaceuticals due to their potential in oncology and therapeutic applications. Learn more about why the industry is excited about radioisotopes in this article.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Pharmacist
FEBRUARY 27, 2024
Pharmacy First could open up routes for community pharmacy to play a greater role in healthcare, the chief pharmaceutical officers (CPhOs) for England, Wales, Scotland and Northern Ireland have suggested. And they agreed that now having a service across all four nations would help the public to view community pharmacies as a place to receive […] The post CPhOs share ambitious plans for Pharmacy First across the four nations appeared first on The Pharmacist.
STAT
FEBRUARY 27, 2024
The Canadian surgeon and urologist Balfour Mount is considered the father of palliative care in North America. He was inspired and mentored by Cicely Saunders, a British nurse and social worker. Before she became a physician, Saunders developed the first modern hospice , St Christopher’s in London in 1967. Mount adapted and transplanted approaches to the care of the terminally ill he had learned at St Christopher’s to the Royal Victoria Hospital in Montreal.
The Pharmacist
FEBRUARY 27, 2024
Boots has launched a recycling scheme for blister packs aimed at customers who cannot leave them for kerbside collection at home. The initiative – which is an extension of the Recycle at Boots scheme – will see customers near participating stores drop off used blister packs for recycling in dedicated collection bins. Blister packs, which […] The post Boots recycling initiative aims to divert blister packs from landfill appeared first on The Pharmacist.
STAT
FEBRUARY 27, 2024
An obesity medication from Viking Therapeutics succeeded in a Phase 2 clinical study, the company said Tuesday, helping patients lose up to nearly 15% of their weight over about three months and further fueling the competition in the exploding obesity drug market. Shares of the San Diego-based company doubled in premarket trading. The trial tested four different weekly injectable doses of the Viking drug, called VK2735, over 13 weeks, with patients seeing a dose-dependent amount of
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
FEBRUARY 27, 2024
Next-generation technology is enabling drug discovery at an entirely new scale, accelerating the process, transforming therapies and advancing precision medicine, and resulting in better patient outcomes. In this podcast, Dr Mohit Jain, founder and CEO of Sapient, discusses personalised disease prediction, diagnostics, and therapies.
STAT
FEBRUARY 27, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi. Hello. It’s Meghana. Today we’re excited to unveil the 2024 STATUS List , a rundown of the 50 most influential people shaping the future of health and life sciences across biotech, medicine, health care, policy, and health tech.
Pharmaceutical Business Review
FEBRUARY 27, 2024
The investment, led by MSD Global Health Innovation Fund and IQ Capital, with contributions from Hoxton Ventures, Creator Fund, Beast Ventures, and Maki.vc, will expedite the progress of Baseimmune’s technology and vaccine candidates. The capital infusion will accelerate the preclinical development of Baseimmune’s three vaccine candidates targeting African swine fever, coronavirus, and malaria.
European Pharmaceutical Review
FEBRUARY 27, 2024
Amgen has opened a new biomanufacturing plant in Central Ohio, US. It is the company ’s most advanced manufacturing facility to date. The new facility, known as Amgen Ohio, “was designed with the latest innovation and technology to deliver safe, reliable medicines for ‘every patient, every time,'” stated Robert Bradway, Chairman and Chief Executive Officer at Amgen. “As part of Amgen’s global biomanufacturing network, Amgen Ohio will play an important role in helping us
pharmaphorum
FEBRUARY 27, 2024
The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract infections (cUTIs) that will now launch later this year, but turned down a rival product from Venatorx.
European Pharmaceutical Review
FEBRUARY 27, 2024
The Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), Dame June Raine, will step down in the Autumn following five years in the role. Dame June will remain in the position until then to support the new Chief Executive’s transition into the role. Leading the MHRA – a five year journey Professor Graham Cooke, interim chair of the MHRA board, remarked that Dame June’s “leadership of the MHRA over the last five years, particularly during the COVID-19 pand
Outsourcing Pharma
FEBRUARY 27, 2024
Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).
Welltopia Pharmacy
FEBRUARY 27, 2024
Compounded Semaglutide: A Modern Approach to Medication Compounded Semaglutide is a sophisticated version of the widely recognized Semaglutide medication, designed
Outsourcing Pharma
FEBRUARY 27, 2024
Biogen Inc. has announced a significant advancement in the treatment of amyotrophic lateral sclerosis (ALS), commonly known as motor neuron disease (MND).
pharmaphorum
FEBRUARY 27, 2024
Looking to the future of clinical trials: Gene therapy, precision medicine, and the ongoing quest for rare disease solutions Mike.
World Pharma News
FEBRUARY 27, 2024
Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for BAY 2927088 for the treatment of adult patients with unresectable or metastatic non-small cell lung cancer (NSCLC) whose tumors have activating HER2 (ERBB2) mutations, and who have received a prior systemic therapy.
pharmaphorum
FEBRUARY 27, 2024
Europe's commercial leaders are gearing up for a faster trial-to-treatment pathway, leveraging CRM technology to empower HCPs and sales teams.
Pharmaceutical Technology
FEBRUARY 27, 2024
Bristol Myers Squibb (BMS) has announced the conclusion of its acquisition of RayzeBio, a radiopharmaceutical company, for $4.1bn.
pharmaphorum
FEBRUARY 27, 2024
UK cancer survival is lagging 10-15 years behind other countries due to lower rates of chemotherapy and radiotherapy, says UCL study backed by CRUK.
Pharma Times
FEBRUARY 27, 2024
Eight out of ten patients who took the test were discharged without needing further testing
pharmaphorum
FEBRUARY 27, 2024
UK biotech Curve Therapeutics raises $51 million in a Pfizer-led Series A that will support its platform for screening drugs within cells.
Pharmaceutical Technology
FEBRUARY 27, 2024
Novo Nordisk has partnered with US startup Neomorph to develop multiple molecular glue degraders for cardiometabolic and rare diseases.
pharmaphorum
FEBRUARY 27, 2024
FDA has turned down Minerva Neurosciences' marketing application for roluperidone as a treatment for the negative symptoms of schizophrenia
Pharma Times
FEBRUARY 27, 2024
The white paper outlines three strategic recommendations to support further research
pharmaphorum
FEBRUARY 27, 2024
Novo Nordisk has signed a wide-ranging deal with US molecular glue biotech Neomorph that could be worth up to $1.46 billion.
PharmaTech
FEBRUARY 27, 2024
CSL will share access to Cytegrity, its proprietary stable production system for lentiviral vector production, with Genezen.
The Pharmacist
FEBRUARY 27, 2024
The IT updates that will allow community pharmacies to send Pharmacy First consultation details to GP patient records with ‘one click’ will be rolled out ‘in the next few weeks’, NHS England (NHSE) has revealed. The system was originally due to be live in time for the Pharmacy First launch, which was postponed to 31 […] The post Pharmacy First GP IT updates could still be weeks away appeared first on The Pharmacist.
BioPharma Dive
FEBRUARY 27, 2024
Analysts viewed results for one of Janux’s drug, a T cell engager aimed at metastatic prostate cancer, as potentially best-in-class in a field that’s crowded with competitors.
Pharmaceutical Technology
FEBRUARY 27, 2024
Making therapies feasible from biological, regulatory, and commercial standpoints drives scalable genetic medicine.
Drug Channels
FEBRUARY 27, 2024
February is longer than usual this year, which means that you’ll have extra time to leap into our monthly curated selection of noteworthy news. In this issue: An update on the retail pharmacy shakeout Arguing for high drug prices A leading researcher provides a 340B reality check Physicians don’t want pharmacists getting uppity Plus, Dave Grohl fights for your right to…have healthcare price transparency?
Expert insights. Personalized for you.
344 
Let's personalize your content